Midven
Future Planet Capital acquires Midven
Midven was founded in 1990 and focuses on West Midlands-based science and technology investments
Mercia et al. sell Allinea to ARM in £18.1m deal
Sale comes eight years after a group of VCs supported the spinout from University of Warwick
unquote” data snapshot: the five biggest buyouts of 2016
The year’s two largest deals, somewhat unusually, took place in Italy and Poland
Midven leads £255,000 round for Audux
UK-based Midven has led the funding round with a £125,000 equity ticket
Rainbow Seed Fund appoints Romanos as consultant venture partner
New recruit leaves position as CEO of Rainbow Seed Fund-backed Crescendo
ERDF backs Midven's Early Advantage Fund with additional £2m
West Midlands-focused vehicle grows to £10m
Midven participates in £251,000 round for Health2Works
VC invests via its Exceed and Early Advantage funds
Spark et al. invest £1.5m in Cytox
UK-based biotech focuses on Alzheimer’s disease
Warwick Audio secures £1.25m
UK-based loudspeaker developer Warwick Audio Technologies has secured £1.25m from a consortium including Midven, Mercia Fund Management (MFM) and Finance Wales.
Midven enters Diverse World
Venture capital firm Midven has invested £255,000 in specialist travel company Diverse World.
Midven invests in Eagle
Midven has injected £590,000 into Eagle Genomics, a provider of outsourced bio-informatics software for the life sciences sector, alongside a number of individual angel investors and syndicates.
Midven backs Learning Labs
Midven has invested £300,000 in Learning Labs' language learning product FlashSticks, which uses 3M’s Post-it notes.
Midven backs Amalyst
Midven has invested in University College London (UCL) spin-off Amalyst, a developer of electro-catalyst technology, alongside funding body UCL Business Plc (UCLB).
Midven in second round for Fertility Focus
Midven has joined angel investors in a seven-figure funding round for fertility diagnosis and treatment firm Fertility Focus.
Porton Capital et al. back Microvisk
Porton Capital, Oxford Technology Management, New Hill, Midven, the Rainbow Seed Fund, Finance Wales and private investors have backed Microvisk Technologies in a third round of finance with £6m.
Oxford Technology Management et al. invest £2.5m in Microvisk
A pool of institutional and angel investors has provided UK medical equipment company Microvisk with a £2.5m round of funding.